Roche's Virtual Pipeline Event
Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema presented at Angiogenesis 2018
| Agenda: | |
|---|---|
| Ophthalmology overview | Jason Ehrlich, M.D. Ph.D., Senior Group Medical Director, Ophthalmology |
| BOULEVARD: Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema | Sascha Fauser, M.D., Head pRED Ophthalmology |
Please register to access the replay* *Privacy notice